Oncothyreon to Present at Cowen and Company 33rd Annual Health Care Conference

Oncothyreon to Present at Cowen and Company 33rd Annual Health Care Conference

PR Newswire

SEATTLE, WA, Feb. 27, 2013

SEATTLE, WA, Feb. 27, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY)
announced today that Robert Kirkman, M.D., President and Chief Executive
Officer, will present at the Cowen and Company 33^rd Annual Health Care
Conference in Boston on Wednesday, March 6, 2013 at 8 a.m. Eastern.

A live and archived webcast of the presentation will be accessible by visiting
the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.

SOURCE Oncothyreon Inc.

Contact:

Investor and Media Relations Contact:
Julie Rathbun
Rathbun Communications
206-769-9219
ir@oncothyreon.com
 
Press spacebar to pause and continue. Press esc to stop.